Social Purpose Corporation Statement (2018) Antimicrobial resistance threatens the very core of human healthcare. ID Genomics’ Social Purpose is simple: to limit bacterial resistance and preserve antibiotics for the good of mankind. We believe that antimicrobial resistance connects every [...]
Today, Seattle-based ID Genomics, Inc.was awarded a grant from the Longitude Prize Discovery Awards, a seed funding program to help teams competing to win the prestigious Longitude Prize. Run by innovation foundation Nesta and supported by Innovate UK as funding partner, the Longitude Prize is a [...]
Many thanks to Clare McGrane at Geek Wire for her narrative describing ID Genomics’ fingerprinting technology. Please read the full article at the link provided here [...]
ID Genomics and the University of Washington have long collaborated on developing cutting-edge technology that improves prescriptions of antibiotics for infectious diseases. To find out more about this collaboration, please read the UW Daily’s account of our technology here: [...]
Many thanks to the Seattle Times for its coverage of ID Genomics’ technology. Please read the full text here: Seattle health startup speeds up lab tests to improve use of antibiotics [...]
SEATTLE (March 29, 2026) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum [...]
ID Genomics will present its pitch in MedTech Innovators’ lightning round on March 15th. Thanks to Wings and Life Sciences Washington for the opportunity! MedTech Innovator [...]
ID Genomics will present a booth advertising its genomics’ Services at Alliance Northwest (http://alliancenorthwest.org). We have been proudly offering Services such as 16S rRNA typing, MultiLocus Sequence Typing, antibiotic susceptibility testing, and Staphylococcus aureus SPA typing to [...]
IDG will present its work at the 13th Annual NIH CAP FeedForward(TM) Sessions. We thank the LARTA Institute for this opportunity and welcome mentor feedback! http://www.larta.org [...]
The Company’s novel approach in matching the infecting bug with the correct drug the first time has been covered by Modern Healthcare: Innovations. Please read the entire text [...]
This archive gathers every news post authored by Kaveri Parker on the ID Genomics site. The stories trace the company's work on rapid bacterial fingerprinting, its collaborations and its public coverage, giving readers a single place to follow how the team has advanced the fight against antimicrobial resistance.